Conclusion
Shilajit is at the crossroads of traditional Ayurvedic medicine (Madhumeha) and still limited modern data : human indices on intermediate markers and open studies, supplemented by preclinical signals . In a responsible approach, it can accompany a structured lifestyle, with quality requirements and regulatory caution .
